MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-18-0031280
Viridis Biopharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹40.48 Cr
▲ 7% YoY
Net profit · FY 2025
₹3.19 Cr
Net margin 7.9%
EBITDA · FY 2025
₹5.7 Cr
EBITDA margin 14.1%
Authorised capital
₹6 Cr
Registered with MCA
Paid-up capital
₹3.42 Cr
Issued & subscribed
Open charges
₹28.6 Cr
Satisfied ₹17.29 Cr
Company age
26 yrs
Est. 2000
Employees · EPFO
59
Provident fund records
About Viridis Biopharma Private Limited
Data last updated:
Viridis Biopharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 June 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2000PTC127016. Its GSTIN is 27AABCV0917D1ZO (Maharashtra).
The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹3.42 Cr. It is led by directors including Ashit Harshad Vora (Managing Director) and Anirudh Dilip Mehta (Managing Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹40.48 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹3.19 Cr (net margin 7.9%) and EBITDA of ₹5.7 Cr (EBITDA margin 14.1%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 7% over five years.
The company has about 59 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.
The company is associated with 1 brand: Viridis BioPharma. As per MCA filings, the company has open charges of ₹28.6 Cr and satisfied charges of ₹17.29 Cr on record.
Viridis Biopharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0031280). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website viridisbiopharma.com.
Company details
CIN U24230MH2000PTC127016
Registration Number 127016
Incorporation Date 06 June 2000
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-18-0031280
Key People
Ashit Harshad Vora Managing Director Anirudh Dilip Mehta Managing Director Anselm Julius Desouza Director Recognitions & Rankings of Viridis Biopharma
Contact details
Viridis Biopharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is viridisbiopharma.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressUnit No. 1503 Universal Majestic, P L Lokhande Marg Chembur, Mumbai, Maharashtra, India – 400043
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Viridis Biopharma Private Limited, buy the company report.
Comprehensive company report
Viridis Biopharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Viridis Biopharma operates one associated brand: Viridis BioPharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing, research, and marketing of active ingredients and formulations in India. | viridisbiopharma.com |
Business activity
The main business activity of Viridis Biopharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Viridis Biopharma Private Limited, buy the company report.
Financials of Viridis Biopharma Private Limited
FY 2025 filings availableViridis Biopharma Private Limited reported revenue of ₹40.48 Cr (up 7% YoY) for FY 2025.
Revenue · FY 2025
₹40.48 Cr ▲ 7%
Net profit · FY 2025
₹3.19 Cr margin 7.9%
EBITDA · FY 2025
₹5.7 Cr margin 14.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 13%
5 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▲ 69%
3 years · compounded
▲ 10%
5 years · compounded
▼ 8%
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 7% growth in the latest year. EBITDA rose 69% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.7 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.19 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.1% | ||||
| Net Profit Margin | 7.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Viridis Biopharma Private Limited, buy the company report.
Board of directors of Viridis Biopharma Private Limited
Viridis Biopharma has 7 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anselm Julius Desouza Also directs: Phytoveda Private Limited, Prorama Biosciences LLP | Director | 06 Jun 2000 | 26 Years 4 Months | Current |
| Purnima Dilip Mehta Also directs: Sanjivani Business Consultants Pvt Ltd | Director | 01 Oct 2015 | 11 Years 0 Months | Current |
| Ashit Harshad Vora Also directs: Mash Ventures LLP, Shavo Norgren (India) Private Limited, Enzyrem Biotech Private Limited and 2 more | Managing Director | 06 Jun 2000 | 26 Years 4 Months | Current |
| Anirudh Dilip Mehta | Managing Director | 06 Jun 2000 | 26 Years 4 Months | Current |
| Vishal Harshad Vora Also directs: Mash Ventures LLP, Shavo Norgren (India) Private Limited, Phytoveda Private Limited and 1 more | Director | 01 Feb 2011 | 15 Years 8 Months | Current |
| Harshad Chhotalal Vora | Director | 06 Jun 2000 | 26 Years 4 Months | Current |
Showing 6 of 7 current directors. View all directors
Peer comparison
Viridis Biopharma Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Biopharma, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sunrise Remedies Private Limited | ₹40.84 Cr (FY 2024) | 3.0% | Ahmedabad, Gujarat, India | |||
| Mefro Organic Limited | ₹40.54 Cr (FY 2025) | -8.0% | Mohali, Punjab, India | |||
| Divine Laboratories Pvt. Ltd. | ₹40.5 Cr (FY 2025) | 13.0% | Vadodara, Gujarat, India | |||
| Viridis Biopharma Private Limitedthis company | ₹40.48 Cr (FY 2025) | ₹3.19 Cr | 7.9% | 7.0% | 59 | Mumbai, Maharashtra, India |
| Shree Anand Life Sciences Limited | ₹40.42 Cr (FY 2023) | -2.0% | Belgaum, Karnataka, India | |||
| Alas Pharmaceuticals Private Limited | ₹40.4 Cr (FY 2021) | Pune, Maharashtra, India | ||||
| Yacca Pharmaceuticals Private Limited | ₹40.38 Cr (FY 2024) | 6.0% | Uttar Pradesh, India | |||
| Vindas Chemical Industries Private Limited | ₹40.36 Cr (FY 2025) | 74.0% | Dhar, Madhya Pradesh, India |
To see the full peer comparison of Viridis Biopharma Private Limited, buy the company report.
Auditor
Viridis Biopharma Private Limited is audited by HSMP & Associates LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| HSMP & Associates LLP | FY 2023 | 100026W |
Shareholding
The shareholding of Viridis Biopharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Viridis Biopharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹28.6 Cr
Satisfied charges
₹17.29 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Sep 2025 | 101176762 | Others | ₹11.25 Cr | Open | |
| 08 Nov 2019 | 100299376 | Others | ₹17.35 Cr | Open | |
| 28 Feb 2015 | 10552455 | Standard Chartered Bank | ₹1.21 Cr | Satisfied | |
| 14 Nov 2014 | 10535046 | Bank of Baroda | ₹5.36 Cr | Satisfied | |
| 17 Nov 2006 | 10031080 | Bank of Baroda | ₹2.6 Cr | Satisfied |
To see the full charge records of Viridis Biopharma Private Limited, buy the company report.
Total charge records: 7 View all charges
Legal cases
No court or tribunal cases involving Viridis Biopharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
Credit ratings & regulatory alerts
Viridis Biopharma Private Limited was last rated by Crisil on 15 Apr 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 15 Apr 2020 |
To see the full credit ratings and regulatory alerts of Viridis Biopharma Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Viridis Biopharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Viridis Biopharma has 2 subsidiary companies and 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
2
Subsidiary companies
1
Associated companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Prorama Biosciences LLP | AAI-1137 | |
| Viridis Personal Care Private Limited | U24100MH2011PTC219706 |
To see the full group structure of Viridis Biopharma Private Limited, buy the company report.
Employees & EPFO
Viridis Biopharma Private Limited has a workforce of 59 employees on its EPFO records as of Mar 31, 2024, across 1 active EPFO establishment.
Employee count
59
Active EPFO establishments
1
Employee growth
31.11%
GST
Viridis Biopharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCV0917D1ZO | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Viridis Biopharma Private Limited, buy the company report.
Recent activity
Viridis Biopharma Private Limited has 9 board changes on record since 2000: 7 appointments and 2 cessations. The latest: Purnima Dilip Mehta ceased to be Additional Director on 30 Sep 2016.
AGM
Viridis Biopharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 11.25 Cr with Charge ID 101176762 was registered on 23 Sep 2025.
Charges
A charge with Others of Rs. 17.35 Cr registered on 08 Nov 2019 with Charge ID 100299376 was modified on 30 May 2025.
Filing
Viridis Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
A charge registered on 28 Feb 2015 via Charge ID 10552455 with Standard Chartered Bank was fully satisfied on 09 Nov 2023.
Charges
A charge with Others amounted to Rs. 17.35 Cr with Charge ID 100299376 was registered on 08 Nov 2019.
Charges
A charge registered on 17 Nov 2006 via Charge ID 10070815 with Bank Of Baroda was fully satisfied on 12 Sep 2019.
Charges
A charge registered on 14 Nov 2014 via Charge ID 10535046 with Bank Of Baroda was fully satisfied on 22 Dec 2016.
Charges
A charge registered on 17 Nov 2006 via Charge ID 10031080 with Bank Of Baroda was fully satisfied on 22 Dec 2016.
Charges
A charge registered on 17 Nov 2006 via Charge ID 10081337 with Bank Of Baroda was fully satisfied on 22 Dec 2016.
Ceased
Purnima Dilip Mehta ceased to be Additional Director.
Appointed
Purnima Dilip Mehta was appointed as Director.
15 earlier events are in the company report.
Frequently asked questions
Viridis Biopharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 June 2000 (26+ years old) and is registered under CIN U24230MH2000PTC127016.
Viridis Biopharma has 7 current directors:
- Ashit Harshad Vora - Managing Director
- Anirudh Dilip Mehta - Managing Director
- Anselm Julius Desouza - Director
- Purnima Dilip Mehta - Director
- Vishal Harshad Vora - Director
- Harshad Chhotalal Vora - Director
- Dilip Sukhlal Mehta - Director
The latest financial statements of Viridis Biopharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Viridis Biopharma is 27AABCV0917D1ZO, registered in Maharashtra.
The CIN (Corporate Identification Number) of Viridis Biopharma is U24230MH2000PTC127016. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Viridis Biopharma was incorporated on 06 June 2000, making it 26+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Viridis Biopharma by revenue are Sunrise Remedies Private Limited, Mefro Organic Limited, Divine Laboratories Pvt. Ltd, Shree Anand Life Sciences Limited, Alas Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (Biopharma, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Purnima Dilip Mehta ceased to be Additional Director on 30 Sep 2016. Purnima Dilip Mehta was appointed as Director on 01 Oct 2015. Tejal Anirudh Mehta ceased to be Director on 01 Oct 2015. Viridis Biopharma has 9 board changes on record in total.
Yes, Viridis Biopharma is registered as a small enterprise under Udyam registration (number: UDYAM-MH-18-0031280).
Viridis Biopharma can be reached through the website viridisbiopharma.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Viridis Biopharma is at Unit No. 1503 Universal Majestic, P L Lokhande Marg Chembur, Mumbai, Maharashtra, India – 400043.